Skip to main content

Table 2 Demographic, laboratory and outcome information of 375 samples in training dataset

From: Predicting COVID-19 disease progression and patient outcomes based on temporal deep learning

Characteristicsa Statisticsb Characteristicsa Statisticsb
Demographics   Outcomes  
Age, mean (years) 58.83 Survival, count and rate 201, 53.6%
Gender Male 224; Female 151 Mortality, count and rate 174, 46.4%
Lab test mean (min, max) patient’s last measurements
 cTnI 747.76 (1.9, 43,905.19) glucose 8.37 (2.43, 32.37)
 Hemoglobin 124.89 (6.4, 178.0) neutrophils count 7.03 (0.85, 31.43)
 Serum chloride 102.73 (77.7, 138.2) Direct bilirubin 9.5 (1.7, 216.3)
 Prothrombin time 16.01 (11.69, 84.22) Mean platelet volume 10.89 (9.04, 14.0)
 procalcitonin 0.99 (0.02, 49.34) ferritin 1634.37 (26.8, 42,402.91)
 Eosinophils(%) 0.56 (0.0, 5.61) RBCW-SD 41.78 (32.5, 83.3)
 sIL-2R 961.52 (61.0, 5608.04) Thrombin time 18.17 (13.0, 133.67)
 Alkaline phosphatase 84.86 (37.18, 481.5) Lymphocyte(%) 16.45 (0.6, 54.83)
 albumin 33.06 (19.1, 45.07) Anti-HCV 0.13 (0.03, 1.85)
 basophil(%) 0.21 (0.0, 1.38) D-D dimer 6.2 (0.21, 29.82)
 Interleukin 10 12.5 (5.0, 500.0) Total cholesterol 3.66 (0.66, 6.11)
 Total bilirubin 16.28 (2.95, 276.0) AST 56.53 (8.0, 1858.0)
 Platelet count 187.78 (1.2, 472.5) Uric acid 297.47 (57.0, 1001.0)
 monocytes(%) 6.66 (0.62, 31.62) HCO3- 22.59 (6.3, 29.7)
 antithrombin 87.57 (20.0, 136.0) calcium 2.1 (1.35, 2.5)
 Interleukin 8 88.08 (5.0, 6385.85) NT-proBNP 3166.26 (5.57, 70,000.0)
 indirect bilirubin 6.85 (1.0, 79.3) LDH 492.12 (143.0, 1867.0)
 RDW 12.94 (10.91, 22.91) platelet large cell ratio 31.63 (16.48, 54.1)
 Neutrophils(%) 76.09 (15.9, 98.1) Interleukin 6 130.37 (1.5, 5000.0)
 Total protein 66.06 (36.7, 79.33) FDP 44.29 (4.0, 182.4)
 Anti-TP 0.17 (0.02, 8.74) monocytes count 0.54 (0.08, 22.75)
 Prothrombin activity 80.97 (16.3, 136.64) PLT distribution width 12.97 (8.42, 25.3)
 HBsAg 10.35 (0.0, 250.0) globulin 32.96 (13.8, 46.04)
 mean corpuscular volume 89.75 (62.3, 110.73) γ-GT 51.79 (10.6, 555.25)
 hematocrit 37.0 (19.9, 51.3) INR 1.3 (0.86, 10.51)
 WBC 15.18 (0.8, 1726.6) basophil count(#) 0.02 (0.0, 0.12)
 Tumor necrosis factorα 12.07 (4.0, 168.0) 2019-nCoV nucleic acid −1.0 (−1.0, −1.0)
 MCHC 344.17 (286.0, 464.33) MCH 30.9 (20.8, 47.67)
 fibrinogen 4.38 (0.5, 8.89) APTT 41.72 (25.59, 100.27)
 Interleukin 1β 6.56 (5.0, 79.44) hs-CRP 72.49 (0.2, 320.0)
 Urea 9.74 (2.17, 68.4) anti-HIV 0.1 (0.05, 0.26)
 lymphocyte count 1.06 (0.13, 35.53) serum sodium 141.06 (122.8, 171.4)
 PH value 6.47 (5.0, 7.54) thrombocytocrit 0.21 (0.05, 0.49)
 Red blood cell count 7.58 (0.1, 749.5) ESR 32.33 (2.0, 102.0)
 Eosinophil count 0.03 (0.0, 0.33) GPT 42.6 (5.0, 1508.0)
 Corrected calcium 2.34 (1.78, 2.67) eGFR 81.07 (2.0, 164.7)
 Serum potassium 4.45 (3.1, 9.86) creatinine 120.38 (39.25, 1497.0)
  1. aCharacteristics have three types - demographics (age and gender), outcomes (survival and mortality) and laboratory test (74 items)
  2. b Statistics is statistical data for corresponding characteristics, such as rate, mean value and range. The statistical methods are described in each column